But with reams of data on the drugs' health benefits beyond reducing obesity—including mitigating heart disease, diabetes, chronic kidney disease, and sleep apnea—most seem to have finally accepted their potentially immense societal value.
Now comes the hard part. These highly effective drugs—GLP-1s—are changing the way obesity is viewed and treated. The changes are coming so fast and could benefit so many that they've created new questions and ethical quandaries for medical professionals, including who should get them.
The theoretical market for Wegovy and Zepbound is massive: The Food and Drug Administration approved them for anyone with a body-mass index of 30 or more—27 or higher for individuals with a weight-related condition like high blood pressure or sleep apnea. Some 57 million working-age Americans with private insurance match those criteria, as do nearly 14 million retirement-age Americans. The expectation is that once started, the drugs will need to be taken for life to maintain the results.
This story is from the December 26, 2024 edition of Financial Express Delhi.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 26, 2024 edition of Financial Express Delhi.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
DDF strengthens its Senior Management Team
DF has further strengthened its senior management team with the appointment of eight senior executives across major departments in recent months.
Excerpts from Russia's President Vladimir Putin's press conference following the 16th BRICS Summit in Kazan
THE 16th BRICS Summit has concluded with great success!
Key outcomes of Russia's BRICS Chairmanship in 2024
In November 26-28, in Yekaterinburg, Russia's Deputy Foreign Minister and Sherpa in BRICS Sergey Ryabkov presided over the final consultations of Sherpas/Sous-Sherpas of the association's countries.
Demerit act by Kohli on Konstas' striking debut
● Indian fined 20% fee for shoulder barge with teenager
Long years of inward-looking policies by govts to blame
IN THE THIRD week of October, the International Monetary Fund said in a blog post: \"Let's start with the good news: it looks like the global battle against inflation has largely been won, even if price pressures persist in some countries.\"
China Clears World's Largest Dam in Tibet Near India Border
CHINA HAS APPROVED construction of the world's largest dam, stated to be the biggest infra project costing $137 billion, on the Brahmaputra river in Tibet close to the Indian border, raising concerns in riparian states India and Bangladesh.
Govt mulls tax relief for middle class
More money in the hands of the middle class may help rev up the economy, the world's fifth-biggest and which grew at its slowest pace in seven quarters between July and September.
Dhindsa: Talk less, deliver more
IT IS SUCH attention to detail that's helping Blinkit leave the competition behind by a mile.
In a first, EatSure launches multi-restaurant ordering
EATSURE, THE D2C platform of online restaurant company Rebel Foods, on Thursday announced the launch of a new feature allowing users to order from multiple restaurants in one order.
A weak rupee may jack up import bills
\"THE COST OF imports of oil & gas will increase with a weakening rupee. However, with the decline in oil prices to $70-75 per barrel now, the impact of weakening rupee would be offset,\" said Girishkumar Kadam, senior vice-president & group head - corporate ratings, at Icra.
